Pelion shareholders tender a success

Shareholders of WSE-listed pharmaceuticals group Pelion tendered 6.94 million shares of the company (37.9 percent stake), enough for the deal to go through. KIPF, along with the company’s owners which controls 25.77 percent of capital and 54.13 percent voting rights, said that the deal would be valid if at least 6.54 million shares were to…

This content is for Silver 6 months, Gold 1 Year and Bronze 2 weeks members only.
Log In Buy Subscription
Pin It